Beta-receptor blockade and myocardial effects of cardiac glycosides.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002301:Cardiac Glycosides / Q000037:antagonists & inhibitors*; D002415:Cats; D002645:Chickens; D046508:Culture Techniques; D004077:Digoxin / Q000037:antagonists & inhibitors; D004285:Dogs; D004558:Electric Stimulation; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D009489:Neurosecretion / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000502:physiology; D010042:Ouabain / Q000037:antagonists & inhibitors; D010210:Papillary Muscles / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology*; D011817:Rabbits; D013045:Species Specificity; D013328:Strophanthins / Q000037:antagonists & inhibitors; D014439:Tyramine / Q000037:antagonists & inhibitors
D000319:Adrenergic beta-Antagonists; D002301:Cardiac Glycosides; D013328:Strophanthins; D010042:Ouabain; D004077:Digoxin; D011433:Propranolol; D009638:Norepinephrine; D014439:Tyramine